多巴胺 D3 受体：神经精神疾病的功能和药理学的当代观点。
Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases.
机构信息
Unité Mixte de Recherche (UMR) 5287, Centre National de la Recherche Scientifique (CNRS), CEDEX, 33000 Bordeaux, France.
Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Normandie University, UNIROUEN, INSERM, U1239, CHU Rouen, 76000 Rouen, France.
出版信息
Biomolecules. 2021 May 11;11(5):713. doi: 10.3390/biom11050713.
Abstract
has launched a Special Issue entitled "Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases [...].
摘要
已推出一期特刊，题为“多巴胺 D3 受体：神经精神疾病的功能和药理学的当代观点[...]”。
相似文献
1
Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases.多巴胺 D3 受体：神经精神疾病的功能和药理学的当代观点。
Biomolecules. 2021 May 11;11(5):713. doi: 10.3390/biom11050713.
2
The dopamine D3 receptor: From preclinical studies to the treatment of psychiatric disorders.多巴胺D3受体：从临床前研究到精神疾病治疗
Eur Neuropsychopharmacol. 2015 Sep;25(9):1399-400. doi: 10.1016/j.euroneuro.2015.07.025. Epub 2015 Aug 4.
3
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.多巴胺D3受体：治疗神经精神疾病的一个治疗靶点。
CNS Neurol Disord Drug Targets. 2006 Feb;5(1):25-43. doi: 10.2174/187152706784111551.
4
Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors.多巴胺领地的迷眩：D3、D2和D1受体的临床作用
CNS Spectr. 2017 Aug;22(4):305-311. doi: 10.1017/S1092852917000426.
5
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs.多巴胺 D3 受体的药理学靶向：选择性药物的可能临床应用。
Eur Neuropsychopharmacol. 2015 Sep;25(9):1437-47. doi: 10.1016/j.euroneuro.2015.07.012. Epub 2015 Jul 21.
6
Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: proteins interacting with the third cytoplasmic loop of dopamine D2 and D3 receptors.深入研究多巴胺信号传递，开发治疗精神障碍的药物：与多巴胺 D2 和 D3 受体第三胞内环相互作用的蛋白质。
J Pharmacol Sci. 2010;114(1):25-31. doi: 10.1254/jphs.10r02fm. Epub 2010 Aug 12.
7
Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance.多巴胺 D2-D3 受体异源二聚体：药理学特性及治疗意义。
Curr Opin Pharmacol. 2010 Feb;10(1):100-7. doi: 10.1016/j.coph.2009.10.001. Epub 2009 Nov 5.
8
D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells.D3受体在一类独特的前额叶锥体神经元中调节兴奋性。
J Neurosci. 2017 Jun 14;37(24):5846-5860. doi: 10.1523/JNEUROSCI.0310-17.2017. Epub 2017 May 18.
9
D-3 receptor agonists: combined action neurologic and neuropsychiatric agents.D-3受体激动剂：神经和神经精神药物的联合作用
J Neurol Sci. 1999 Feb 1;163(1):2-3. doi: 10.1016/s0022-510x(98)00306-2.
10
[The dopamin D3 receptor--the gray eminence of pharmacotherapy?].[多巴胺D3受体——药物治疗的关键所在？]
Neuropsychopharmacol Hung. 2010 Sep;12(3):405-11.
本文引用的文献
1
Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods.配体与多巴胺 D3 受体相互作用的 PET：计算和体外方法。
Biomolecules. 2021 Apr 2;11(4):529. doi: 10.3390/biom11040529.
2
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.神经元多巴胺D3受体：对临床前研究和中枢神经系统疾病的转化意义
Biomolecules. 2021 Jan 14;11(1):104. doi: 10.3390/biom11010104.
3
Plasticity-Related Activity in the Hippocampus, Anterior Cingulate, Orbitofrontal, and Prefrontal Cortex Following a Repeated Treatment with D/D Agonist Quinpirole.重复给予 D/D 激动剂喹吡罗后海马、前扣带回、眶额和前额皮质中的与可塑性相关的活动。
Biomolecules. 2021 Jan 11;11(1):84. doi: 10.3390/biom11010084.
4
Smoking Genes: A Case-Control Study of Dopamine Transporter Gene () and Dopamine Receptor Genes (, and ) Polymorphisms and Smoking Behaviour in a Malay Male Cohort.吸烟基因：多巴胺转运体基因（）和多巴胺受体基因（、和）多态性与马来男性队列吸烟行为的病例对照研究。
Biomolecules. 2020 Dec 3;10(12):1633. doi: 10.3390/biom10121633.
5
The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats.长效 D3 部分激动剂 MC-25-41 可减弱 Sprague-Dawley 大鼠可卡因的觅药动机。
Biomolecules. 2020 Jul 18;10(7):1076. doi: 10.3390/biom10071076.
6
Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.用于改善阿尔茨海默病认知和现实世界功能的双效药物：聚焦5-HT6和D3受体作为关键靶点。
Neuropharmacology. 2020 Oct 15;177:108099. doi: 10.1016/j.neuropharm.2020.108099. Epub 2020 Jun 7.
7
Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.卡利拉嗪（RGH-188），一种多巴胺 D3 受体优先结合的、D3/D2 多巴胺受体拮抗剂-部分激动剂抗精神病候选药物：体外和神经化学特征。
J Pharmacol Exp Ther. 2010 Apr;333(1):328-40. doi: 10.1124/jpet.109.160432. Epub 2010 Jan 21.
8
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.一种新型多巴胺受体（D3）作为抗精神病药物靶点的分子克隆与特性分析
Nature. 1990 Sep 13;347(6289):146-51. doi: 10.1038/347146a0.
Zotero 插件